Comprehensive Assessment of Neuropathy and Metabolic Parameters in Type 1 Diabetic Patients with or Without Using Continuous Glucose Sensors
The present study was conducted in type 1 diabetic (T1DM) patients to evaluate the metabolic and glycemic control as well as the manifestations of neuropathy. The impact of continuous glucose monitoring (CGM) on the measured parameters was also analyzed. A total of 61 T1DM patients (age: 42.5 ± 1.8...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2025
|
| Sorozat: | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
26 No. 5 |
| Tárgyszavak: | |
| doi: | 10.3390/ijms26052062 |
| mtmt: | 35793186 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/36166 |
| LEADER | 02755nab a2200325 i 4500 | ||
|---|---|---|---|
| 001 | publ36166 | ||
| 005 | 20250228143116.0 | ||
| 008 | 250228s2025 hu o 000 eng d | ||
| 022 | |a 1661-6596 | ||
| 024 | 7 | |a 10.3390/ijms26052062 |2 doi | |
| 024 | 7 | |a 35793186 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bordács Barbara Anikó | |
| 245 | 1 | 0 | |a Comprehensive Assessment of Neuropathy and Metabolic Parameters in Type 1 Diabetic Patients with or Without Using Continuous Glucose Sensors |h [elektronikus dokumentum] / |c Bordács Barbara Anikó |
| 260 | |c 2025 | ||
| 300 | |a 11 | ||
| 490 | 0 | |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |v 26 No. 5 | |
| 520 | 3 | |a The present study was conducted in type 1 diabetic (T1DM) patients to evaluate the metabolic and glycemic control as well as the manifestations of neuropathy. The impact of continuous glucose monitoring (CGM) on the measured parameters was also analyzed. A total of 61 T1DM patients (age: 42.5 ± 1.8 years, DM duration: 22.8 ± 1.6 years, mean ± SE) participated in the study. In total, 24 patients had CGM sensors and 37 did not. Cardiovascular autonomic neuropathy was assessed using cardiovascular reflex tests. Peripheral sensory function was evaluated by a Neurometer and calibrated tuning fork on the upper and lower limbs. Metabolic status was characterized by the determination of triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, and glycated haemoglobin (HBA1c). A positive correlation was found between HbA1c and triglyceride levels (r = 0.28, p < 0.05). CGM users and non-users differed in triglyceride (0.9 ± 0.1 vs. 1.24 ± 0.12 mmol/L, p < 0.05), HDL cholesterol (1.7 ± 0.1 vs. 1.4 ± 0.1 p < 0.05 mmol/L), and HbA1C (7.5 ± 0.2 vs. 8.3 ± 0.3%, p < 0.05) levels as well. Significant differences were found for the Valsalva ratio, Neurometer, and calibrated tuning fork results between CGM users and non-users. This study found a significant correlation between HbA1c and triglyceride levels in T1DM. CGM use resulted in improved metabolic parameters and less autonomic and sensory nerve damage. As a novel finding, CGM is presumed to prevent both micro-, and macrovascular complications and, by this way, potentially reducing mortality rates. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Várkonyi Ákos |e aut |
| 700 | 0 | 1 | |a Valkusz Zsuzsanna |e aut |
| 700 | 0 | 1 | |a Nyiraty Szabolcs |e aut |
| 700 | 0 | 1 | |a Pósa Anikó |e aut |
| 700 | 0 | 1 | |a Menyhárt Adrienn |e aut |
| 700 | 0 | 1 | |a Lengyel Csaba Attila |e aut |
| 700 | 0 | 1 | |a Kempler Péter |e aut |
| 700 | 0 | 1 | |a Kupai Krisztina |e aut |
| 700 | 0 | 1 | |a Várkonyi Tamás |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/36166/1/Bordacs.pdf |z Dokumentum-elérés |